Telesta Therapeutics
id:
telesta-therapeutics-237-6420559
title:
Telesta Therapeutics
text:
Telesta Therapeutics Inc. was a publicly traded, Canadian pharmaceutical company based in Montreal, Quebec. It was acquired by ProMetic Life Sciences in 2016. CEO Michael Berendt; prior to joining Telesta, was the president and CEO of Aegera Therapeutics. Telesta was listed on the Toronto Stock Exchange under the symbol TST.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Telesta_Therapeutics
date created:
date modified:
2024-01-29T08:37:07Z
main entity:
{"identifier":"Q19903693","url":"https://www.wikidata.org/entity/Q19903693"}
image:
fields total:
13
integrity:
13